Rinsho Ketsueki
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
Markedly Improved Evans' Syndrome with Pulse Therapy of Methylprednisolone
Koichi MORITomoji KUROSUMasaru SHIOHIRAHidetoshi SHIGEFUKUMasaru NAKANOOsamu YOSHIKAWAKenjiro ITOHShigeyuki OSAMURA
Author information
JOURNAL RESTRICTED ACCESS

1986 Volume 27 Issue 2 Pages 185-190

Details
Abstract
A 56-year-old female, who had been diagnosed as ITP and treated with prednisolone for 3 years, was recently complicated with autoimmune hemolytic anemia and was thought to be Evans' Syndrome.
Usual dose of prednisolone was orally given at the first time and anemia was markedly improved except Thrombocytopenia.
Therefore pulse therapy (Methylprednisolone 1000 mg 3 days iv) was carried out.
As soon as pulse therapy was done, not only anemia but also thrombocytopenia was markedly improved except decrease of serum immunoglobulin (especialy IgG).
The remission continued for 6 months. But pulse therapy had to be done again because of Thrombocytopenia.
Although the recovery of the platelet was slightly delayed, the effect of pulse therapy remained stable for 5 months.
From these results it was suggested that one shot pulse therapy was markedly effective remission induction of Evans' syndrome.
Content from these authors
© 1986 The Japanese Society of Clinical Hematology
Previous article Next article
feedback
Top